A detailed history of Bahl & Gaynor Inc transactions in Mckesson Corp stock. As of the latest transaction made, Bahl & Gaynor Inc holds 721 shares of MCK stock, worth $415,843. This represents 0.0% of its overall portfolio holdings.

Number of Shares
721
Previous 721 -0.0%
Holding current value
$415,843
Previous $421,000 15.44%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$518.81 - $607.81 $5,188 - $6,078
-10 Reduced 1.37%
721 $421,000
Q1 2024

May 10, 2024

SELL
$473.42 - $539.26 $4,734 - $5,392
-10 Reduced 1.35%
731 $392,000
Q4 2023

Feb 02, 2024

BUY
$437.42 - $470.64 $7,873 - $8,471
18 Added 2.49%
741 $343,000
Q3 2023

Nov 03, 2023

BUY
$402.4 - $446.42 $290,935 - $322,761
723 New
723 $314,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.